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Figure S17 Synthesis of 3,7-Dihydroxy-6-methoxycoumarin (6) A stirred solution of 8 (230 mg, 0.79 mmol) in 3 M HCl (aq) (7.5 mL) and acetic acid (7.5 mL) was heated to 130 o C for 16 h. The solution was cooled to RT, and the solvent was removed in vacuo.
The residue was dissolved in 1:1 dichloromethane/acetone, pre-loaded on to silica, and purified by silica gel column chromatography (dichloromethane to 4:1 dichloromethane/acetone) to yield the title compound 6 (96 mg, 59%) as a yellow powder. Spectra was identical to that previously reported for this compound. Imaging and image analysis. Plates were imaged automatically using Operetta ™ (PerkinElmer), a high content imaging system using a 20X high numerical aperture S8 objective lens. 6 images per well for each wavelength were collected. Individual cell segmentation was done using the Harmony® software and measurements for each cell were performed generating 38 parameters from 6 dyes: Dapi, α-tubulin staining, MitoTracker® Orange CMTMRos, LC3b staining, LysoTracker® Red DND-99 and EEA1 staining. The normality of the data was checked for each parameter and a log2 transformation was made when required. The measurements were then converted to a score.
S4 Structural elucidation of iotrochotadines A -D (2 -5)
Iochotadine A (2) and HMBC correlations were used to assign the 1-(5-aminopentyl) guanidine partial structure. An HMBC correlation from H6' to an imine carbon at δ C 156.6 depicted in Figure S1 , confirmed the connectivity between the aminopentyl chain and the terminal guanidine group. Comparison of the spectroscopic data with the known natural products that contain a similar amino alkyl guanidine moiety, 4,5 confirmed the structural assignment of this fragment. The methylene singlet resonance at δ H 3.38
showed HMBC correlations to both the phenyl ring carbons and a carbonyl resonance and was assigned to a benzylic position alpha to a carbonyl group, with the S9 spectroscopic data in close agreement with other natural products that contain the phenyl acetyl moiety. 6, 7 The connectivity between the two partial substructures was established via HMBC correlations between NH1' and H2' methylenes to the carbonyl at C1 to complete the structure of iotochotadine A (2). LLE extract and a single fraction generated from the same biota. The top spectrum shows the crude extract whereas the bottom spectrum is that of a single fraction (LLEF-4). The extended regions A and B clearly demonstrate that while the crude extract spectra are dominated by the major compounds, the fraction spectra are far less complicated and allow the minor metabolites to be destinguished. , Cell 4 -cell ratio width to length, Cell 5 -cell roundness, Tubulin 1 -tubulin marker intensity in cytoplasm, Tubulin 2 -tubulin marker intensity in outer region of cytoplasm, Tubulin 3 -tubulin marker intensity in inner region of cytoplasm, Tubulin 4 -tubulin marker texture, Mitochondria 1 -mitochondria marker intensity in cytoplasm, Mitochondria 2 -mitochondria marker intensity in outer region of cytoplasm, Mitochondria 3 -mitochondria marker intensity in inner region of cytoplasm, Mitochondria 4 -mitochondria marker texture, LC3b 1 -LC3b marker intensity in cytoplasm, LC3b 2 -LC3b marker intensity in outer region of cytoplasm, LC3b 3 -LC3b marker intensity in inner region of cytoplasm, LC3b 4 -LC3b marker texture, Lysosome 1 -lysosome marker intensity in cytoplasm, Lysosome 2 -lysosome marker intensity in outer region of cytoplasm, Lysosome 3 -lysosome marker intensity in inner region of cytoplasm, Lysosome 4 -lysosome marker texture, EEA1 1 -number of EEA1 spots in cytoplasm, EEA1 2 -number of EEA1 spots in inner region of cytoplasm, EEA1 3 -number of EEA1 spots in outer region of cytoplasm, EEA1 4 -number of EEA1 spots per area of cytoplasm, EEA1 5 -number of EEA1 marker spots per area of outer region, EEA1 6 -number of EEA1 marker spots per area of inner region, EEA1 7 -EEA1 marker spot signal in cytoplasm, EEA1 8 -EEA1 marker spot signal in outer region of cytoplasm, EEA1 9 -EEA1 marker spot signal in inner region of cytoplasm, EEA1 10 -EEA1 marker texture. 
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